A systematic formulation optimization process for a generic pharmaceutical tablet

Pharmaceutical Technology

Volumn 22, Issue 5, 1998, Pages 48-62

  Hwang, Ruey Ching ^a   Gemoules, Mary K ^a   Ramlose, Daniel S ^a   Thomasson, Catherine E ^a  

^a MALLINCKRODT PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENERIC DRUG;

ARTICLE; DRUG DOSAGE FORM; DRUG FORMULATION; PARTICLE SIZE; STATISTICAL ANALYSIS; TABLET;

EID: 0031980946     PISSN: 01478087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. D.F. Fonner, Jr., J.R. Buck, and G.S. Banker, "Mathematical Optimization Techniques in Drug Product Design and Process Analysis," J. Pharm. Sci. 59 (11), 1587-1598 (1970).
2. C. Constant, C. Mathis, and A. Stamm, "Tablet Formulation: Genichi Taguchi's Approach," Drug Dev. Ind. Pharm. 19 (12), 1461-1477 (1993).
3. D. Vojnovic, M. Moneghini, and F. Rubessa, "Simultaneous Optimization of Several Response Variables in a Granulation Process," Drug Dev. Ind. Pharm. 19 (12), 1479-1496 (1993).
4. P. Wehrle, D. Korner, and S. Benita, "Sequential Statistical Optimization of a Positively Charged Submicron Emulsion of Miconazole," Pharm. Dev. Technol. 1(1), 97-111 (1996).
5. M. Harihara, V. Gupta, and J. Price, "Optimization of Sustained-Release Tablet Formulation: A Four-Component Mixture Experiment," Pharm. Dev. Technol. 2 (4), 365-371 (1997).
6. S. Porter, R. Verseput, and C. Cunningham, "Process Optimization Using Design of Experiment," Pharm. Technol. 21 (10), 60-70 (1997).
7. G.A. Hileman, S.M. Upadrashta, and S.H. Neau, "Drug Solubility Effects on Predicting Optimum Conditions for Extrusion and Spheronization of Pellets," Pharm. Dev. Technol. 2(1), 43-52 (1997).
8. J. Heinamaki et al., "Optimization of Aqueous-Based Film Coating of Tablets Performed by a Side-Vented Pan-Coating System," Pharm. Dev. Technol. 2 (4), 357-364 (1997).
9. Arom Tattawasart and Anthony Armstrong, "The Formulation of Lactose Plugs for Hard-Shell Capsule Fills," Pharm. Dev. Technol. 2 (4), 335-343 (1997).
10. L.D. Torbeck and R.C. Branning, "Designed Experiments - A Vital Role in Validation," Pharm. Technol. 20 (6), 108-114 (1996).
11. L.D. Torbeck, "Ruggedness and Robustness with Designed Experiments," Pharm. Technol. 20 (3), 168-172 (1996).
12. D.R. Lu, K. Abu-Izza, and W. Chen, "Optima: A Windows-Based Program for Computer-Aided Optimization of Controlled-Release Dosage Forms," Pharm. Dev. Technol. 1 (4), 405-414 (1996).
13. Ray C. Rowe, "Intelligent Software Systems for Pharmaceutical Product Formulation," Pharm. Technol. 21 (3), 178-188 (1997).
14. J. Bourquin et al., "Basic Concepts of Artificial Neural Networks (ANN) Modeling in the Application to Pharmaceutical Development," Pharm. Dev. Technol. 2 (2), 95-109 (1997).
15. J. Bourquin et al., "Application of Artificial Neural Networks (ANN) in the Development of Solid Dosage Forms," Pharm. Dev. Technol. 2 (2), 111-121 (1997).
16. N. Ebube et al., "Relating Formulation Variables to In Vitro Dissolution Using Artificial Neural Network," Pharm. Dev. Technol. 2 (3), 225-232 (1997).
17. R. Hwang, M.K. Gemoules, and D.S. Ramlose, "A Systematic Approach for Optimizing the Blending Process of a Direct-Compression Tablet Formulation," Pharm. Technol. 22 (3), 158-170 (1998).